You searched for "retinal"
ChatGPT cannot pass FRCOphth examinations: implications for ophthalmology and large language model artificial intelligence
Large language models are generating a lot of hype for artificial intelligence, but can they assist patients and practitioners in ophthalmology? Introduction Deep learning (DL) has emerged in ophthalmology as an exciting form of artificial intelligence (AI) most commonly applied...Newer generation IOL platforms designed for high-quality visual performance after cataract surgery
Expanding intraocular lens (IOL) capabilities provide broadening options, ranging from next-generation monofocal IOLs for basic cataract surgery, to specialised premium IOLs for lens-based presbyopia correction and astigmatism correction at the time of cataract surgery. Rod McNeil considers several newer alternative...Scope Eyecare joins ABDO National Resource Centre as a new gold digital sponsor
The ABDO National Resource Centre (NRC) based in Birmingham has secured a new gold digital sponsor in Scope Eyecare. Scope Eyecare a leading healthcare and pharmaceuticals company specialising in ophthalmic and general health solutions, is proud to announce its sponsorship...Is patient masking leading to an increase in post-op infection after eyelid surgery?
Due to the COVID-19 pandemic, the use of facemasks or face coverings in the clinical setting has become necessary. It is important to recognise that facemasks can be a source of infection after eye surgery and consider ways to minimise...Corneal transplantation in the United Kingdom: are we blind to the challenges that still exist after the Organ Donation Bill?
Corneal transplantation (CT) is a significant treatment option for a huge number of patients in the United Kingdom (UK) [1]. For an individual, CT results in a substantial improvement in quality of life. Penetrating keratoplasty with full thickness grafting has...
Retinoblastoma risk factors for recurrence
This study evaluates risk factors for local tumour recurrence of main solid tumour, subretinal seed, vitreous seed and new tumour formation in eyes with retinoblastoma (RB) management with primary chemotherapy over 20 years of follow-up. The study included 960 eyes...Assessing everyday visual function in dry AMD – what matters to the person?
Age-related macular degeneration (AMD) is the primary cause of blindness in the developed world and is accountable for more than one half of sight impairment registrations within England and Wales [1]. AMD is prevalent in people aged 60 years and...Regulatory drug evaluations and expedited review initiatives: EU and US perspectives
The European Medicines Agency (EMA) and United States Food and Drug Administration (FDA) each conduct independent assessments of benefit-risk profile when evaluating applications to market new or modified medicines, and their respective decision-making is guided by distinct legislation, procedures and...Cabinet Secretary backs call for major shift in venue accessibility
Scotland’s Culture Secretary Angus Robertson has thrown his support behind Sight Scotland’s Accessible Venues Campaign, which aims to make every theatre, concert hall and cultural venue fully accessible for people with vision impairment. Mr Robertson recently met with members of...Conference Report: Building on a successful 2024: A week of learning at the Kabgayi Eye Unit
2024 was an exceptional year for us at Kabgayi Eye Unit (KEU). We hosted Rwanda’s first-ever international ophthalmology conference, established the Kabgayi Learning and Simulation Centre (KLAS) – a dedicated wet lab and skills transfer centre, and launched our training...
